DAVE — Q4 FY25 Earnings Review

Analyst: Bear (PaulWBryant / Drew) Date: 2026-04-06 Quarter: Q4 FY25 (Dec-2025) Call Date: March 2, 2026

Prior Beliefs

I haven't written about Dave specifically, but applying my framework to what I know heading into Q4:

1. Revenue: Expected ~$160M for Q4, given the Q3 run-rate of $150.7M and management's tightened FY guide of $544-547M (implying $160-165M Q4). Revenue growth should be in the low-to-mid 60s% YoY based on the trajectory.
2. EBITDA: Expected 40-42% margins, continuing the progression from 39% in Q3. Absolute EBITDA of $65-70M.
3. Credit quality: Expected DPD to remain around 2.0-2.3%, consistent with guidance of sub-2.1%.
4. MTMs: Expected ~2.8-2.9M, continuing mid-to-high-teens growth.
5. FY26 guidance: Expected material deceleration — the growth algorithm of mid-teens MTM + low double-digit ARPU implies ~30% organic growth baseline.

Updated Beliefs — Q4 FY25 Results vs. Expectations

Overall: The quarter exceeded expectations on almost every metric. The margin expansion to 44.5% EBITDA was the biggest surprise — I would not have expected 550bps of sequential improvement in a single quarter.

Financial Table — FY25 Quarterly Progression

| | Q1_FY25 | Q2_FY25 | Q3_FY25 | Q4_FY25 | | | Mar-25 | Jun-25 | Sep-25 | Dec-25 | |---|---|---|---|---| | Revenue ($m) | 108.0 | 131.8 | 150.7 | 163.7 | | YoY % | 46.7% | 64.5% | 62.9% | 62.4% | | QoQ % | +7.1% | +22.0% | +14.3% | +8.6% | | Non-GAAP GP ($m) | 83.4 | 92.0 | 104.2 | 121.9 | | Non-GAAP GM % | 77.0% | 70.0% | 69.0% | 74.0% | | Adj EBITDA ($m) | 44.2 | 50.9 | 58.7 | 72.9 | | Adj EBITDA Margin % | 40.9% | 38.6% | 39.0% | 44.5% | | Adj EPS (diluted) | $2.22 | $2.78 | $4.45 | 3.69||MTMs(M)|2.50|2.60|2.77|2.93||Originations(B) | 1.50 | 1.80 | 2.00 | 2.20 | | 28-day DPD % | 1.50% | 2.40% | 2.33% | 1.89% | | SBC ($m) | 7.5 | 8.3 | 7.2 | 6.9 | | Diluted Shares (M) | 14.6 | 14.6 | 14.5 | 14.4 |

FY25 Full Year: Revenue $554.2M (+60%) | Adj EBITDA $226.7M (40.9%) | GAAP NI $195.9M | SBC $29.9M

Valuation Snapshot

Valuation Assessment: By my revenue-PEG heuristic — revenue growth rate of 26% vs P/S of 3.4x — this stock is not expensive. The growth rate meaningfully exceeds the P/S ratio. At 7.9x forward EBITDA and 11.9x forward earnings, this is priced like a value stock, not a 26% grower with expanding margins. The market either doesn't believe the growth is sustainable or is assigning a permanent fintech/regulatory discount.

Key Observations

1. The Growth Algorithm — Durable but Decelerating

In other words, management is telling you that FY25's 60% growth was the anomaly, not the baseline. The sustainable growth algorithm is mid-teens MTM growth + low double-digit ARPU expansion = roughly 25-30%. This is what FY26 guidance reflects.

The question I want to answer: was FY25 a one-time step-up from the fee restructuring and CashAI improvements, or does this business have structural tailwinds that sustain 40%+ growth? I lean toward the former. The fee restructuring (moving from optional tips to mandatory pricing) was a monetization reset that pulled forward ARPU gains. CashAI v5.5 expanded origination sizes and improved credit quality simultaneously. Both are powerful but inherently one-time in nature — you can't restructure fees or launch a new underwriting model every year.

That said, 25-28% growth at these margins is still very good. The deceleration is from an extraordinary level, not from a concerning one.

2. EBITDA Margins — The Real Story

The progression from -3.8% (Q3 FY23) to 44.5% (Q4 FY25) in nine quarters is remarkable. The 86% flow-through on incremental revenue in FY25 tells you this is a high-operating-leverage business. Fixed costs (comp + tech + other) were 19% of revenue in Q4, down 800bps YoY. SBC is declining both absolutely ($6.9M vs $10.1M) and as a percentage of revenue (4.2% vs 10.0%). The share count is declining. These are real quality markers.

The CFO guides to continued margin expansion in FY26 (midpoint ~42.5% EBITDA margin). At the algorithm growth rate, operating leverage should continue to drive margin expansion for several more years. This is the part of the story I find most compelling.

3. Credit Quality — Input, Not Output

Management frames credit performance as "an input, not an output." In other words, they're not optimizing for the lowest possible DPD — they're optimizing for maximum gross profit dollars. CashAI v5.5 enables them to increase origination sizes (avg advance +20% YoY to $214) while keeping or improving credit outcomes. The 8-10 day book turnover gives them rapid feedback loops to adjust underwriting.

Q4 DPD of 1.89% was well below the 2.1% guidance ceiling. The net monetization rate of 4.8% (ExtraCash revenue net of 121-day losses as % of originations) is a record and expanded 29bps YoY.

I need to be honest about the risk here: this portfolio turns over every 8-10 days, which means the credit data is always current — but it also means a sudden spike in delinquencies would flow through to results almost immediately. The short duration is both a strength (fast feedback) and a risk (fast deterioration in a downturn). CEO Wilk saying "regardless of the broader macroeconomic environment" makes me a little uneasy. You always want management that acknowledges tail risks rather than dismisses them.

4. The DOJ/FTC Overhang

The DOJ lawsuit (filed late 2024, amended December 2024) alleges deceptive marketing of cash advances, undisclosed fees, and non-consensual tips. Dave has already restructured its fee model in response — eliminating optional tips and express fees, moving to a transparent subscription + processing fee model. The case is still pending with no resolution timeline.

This matters for two reasons:

• Financial risk: Potential civil penalties, though magnitude is unclear. The $4.5M in legal settlement and litigation expenses in FY25 is manageable but may increase.
• Regulatory risk: The case could result in restrictions on how Dave markets and prices its products. Management has preemptively addressed the core complaints by restructuring fees, which is smart, but the case names CEO Wilk personally — that's unusual and suggests the DOJ is serious.

This is a real overhang that likely explains part of the valuation discount.

5. The Balance Sheet and Capital Allocation

Net cash of $48M at year-end. The 175Min0200M in liquidity), Dave should have substantial capital flexibility.

The 300Mbuybackauthorizationrepresents 12.5173/share, they could retire ~1.7M shares (12% of float). With SBC declining, this creates a meaningful per-share growth tailwind.

Capital allocation priorities are sensible: organic growth first, buybacks second, debt repayment third. No acquisitions. No dividends. This is what I want to see.

6. Pay-in-4 — Free Option or New Risk?

The BNPL product (limits 50-2x ExtraCash, so ~107−428) enters customer testing April 2026 with no meaningful 2026 revenue. Management expects scaling in 2027.

This is interesting but introduces new risks:

• Longer duration credit — BNPL is not 8-10 day turnover. Loss experience will be different and less immediate.
• Cannibalization — Management acknowledges "some" cannibalization but says Pay-in-4 has higher LTV. I'd want to see the data before accepting this.
• New competitive landscape — Competing with Affirm, Klarna, Afterpay. Different game than short-duration cash advances where Dave has a moat.

For now, it's a free option not baked into guidance. If it works, it's incremental. If it doesn't, the base business is unaffected.

What I Like

1. Valuation is reasonable to cheap. 3.4x forward P/S, 7.9x forward EBITDA, 11.9x forward earnings for a 26% grower with expanding margins. Revenue-PEG is favorable.
2. Profitability quality is high. EBITDA margin expanding, SBC declining, share count declining, operating leverage proven. FY25 EBITDA flow-through of 86% is excellent.
3. The growth algorithm is quantifiable. Mid-teens MTM x low double-digit ARPU = ~25-30%. With only 1.6% of 185M TAM penetrated, the runway is long.
4. Credit model is differentiated. 8-10 day book turnover + CashAI underwriting creates fast iteration loops. Net monetization rate expanding at record levels.
5. Management has a beat-and-raise track record. Four consecutive guidance raises in FY25. CFO explicitly says the guide is "conservative" and they want "ability to outperform."
6. Capital allocation is shareholder-friendly. $300M buyback, declining SBC, no dilutive M&A.

What Concerns Me

1. Sharp growth deceleration. 60% to 26% is the steepest year-over-year growth deceleration I can recall seeing in a company I'd consider owning. Even if the guide is conservative and they deliver 35%, that's still a major step-down.
2. Macro sensitivity. Dave serves underserved consumers (avg income $3K-4K/month). These are the first people hit in a recession. "Regardless of macro" is the wrong thing to say when your customers are the most macro-sensitive cohort in America.
3. DOJ/FTC litigation. Pending case with CEO personally named. No resolution timeline. Could impose restrictions beyond what Dave has already preemptively implemented.
4. Revenue quality questions. Processing and overdraft service fees grew from $66M to $140.7M in Q4 YoY (+113%). This line item is doing a lot of heavy lifting. I'd want to understand the sustainability of this fee revenue stream.
5. ExtraCash receivables growth. +$121M YoY to $297M. This is working capital absorption from the business model — the faster they grow, the more capital is tied up in receivables. The Coastal transition is supposed to solve this, but it's been pushed back (was "early 2026," now "mid-2026").
6. Seasonal patterns not yet fully understood. Only a few years of operating history at scale. Q1 is seasonally strong due to tax refunds, Q2 typically sees higher DPD. Hard to separate seasonality from trend with limited history.

The Deceleration Math

Let me be precise about what the FY26 guide implies:

The EPS growth of only 10% despite 26% revenue growth and margin expansion is notable. This implies higher tax rate normalization (guided 23%, up from negative in FY25 due to valuation allowance releases). FY25 GAAP NI of $195.9M was boosted by $27.8M in tax benefits and $32.6M in valuation allowance releases. FY26 at 23% tax rate normalizes this.

On a like-for-like Adj EPS basis, $14.50 vs $13.18 = +10% looks light. But this is likely conservative — management has earned the benefit of the doubt on guidance after beating initial FY25 guide by 30%.

Thesis Formation (First Look)

Dave is a well-run, profitable, fast-growing fintech with strong unit economics and a reasonable valuation. The numbers match the theory in almost every respect.

However, I have two structural concerns that prevent me from being fully enthusiastic:

1. The business model serves financially stressed consumers. In a good economy, this is a growth tailwind. In a bad economy, this is a credit time bomb. Management dismissing macro risk is not reassuring.

2. The FY25-to-FY26 deceleration is steep. Even if management is conservative (and they have been), going from 60% to 30-35% is a fundamentally different growth story. The market will re-rate this as a value/GARP stock, not a growth stock.

My framework says: the numbers have to match the theory, and here they do. Strong beat on Q4. Guidance is conservative based on track record. Margins are expanding. Credit quality is improving. Valuation is undemanding. But I'm watching the growth deceleration and macro sensitivity closely.

If I held this stock, I'd hold it. The valuation provides a margin of safety — at 3.4x forward P/S and 7.9x forward EBITDA, you're not paying a growth premium. You're paying for the business you see today.

If I were considering adding, I'd want to see one more quarter to confirm the growth algorithm baseline before building a position. Q1 FY26 results (expected May 2026) will be the first data point on whether 26% is the floor or the ceiling.

Watch Items for Q1 FY26

1. Revenue growth rate — Does YoY growth stabilize in the high-20s to low-30s, or decelerate further?
2. MTM growth — Did mid-teens growth hold? Any impact from macro weakness?
3. DPD / credit quality — Q1 benefits from tax refunds. Look at the seasonal-adjusted trend.
4. Coastal transition progress — Is mid-2026 still on track?
5. Buyback activity — How aggressively are they deploying the $300M authorization?
6. DOJ litigation — Any material developments?
7. Pay-in-4 — Customer testing started April 2026. Early reads on adoption?

Verdict

Quarter Grade: A

This was a clean, strong quarter. Revenue beat, EBITDA beat, credit improvement, record unit economics, reasonable FY26 guidance with room to beat. Seven all-time-highs in a single quarter. Management earned credibility with FY25 execution.

Thesis Status: Intact (New)

First review. Establishing thesis: Dave is a profitable, reasonably valued fintech growing 25-30% with expanding margins and strong unit economics. The growth algorithm (mid-teens MTM + low double-digit ARPU) is sustainable given TAM penetration of 1.6%. Downside risks are macro sensitivity, regulatory overhang, and the business model's dependence on financially stressed consumers.

Action: Watchlist — Monitor for Entry

Valuation is attractive. Execution is strong. But this is a first look, and I want to see the growth algorithm in steady-state (post-FY25 anomaly) before building conviction. Q1 FY26 will be the proving ground.

I could be wrong — the conservative guidance and beat-and-raise pattern could mean FY26 delivers 35-40% growth, making this a clear buy at current prices. But I'd rather let conviction build over time than let enthusiasm get ahead of the data.

Bear

"The numbers have to match the theory." — In DAVE's case, they do. The question is whether the theory holds through a growth deceleration and potential macro headwinds. Time will tell.